North American Rigid Endoscopes Market Research Report
- Report Code: RI 1000
- Publish Date: Upcoming
The North American Rigid Endoscopes Market, mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures was pegged at $1.03 billion in 2013 and expected to be $1.41 billion by 2018, growing at a CAGR of 6.5%.
The report “Rigid Endoscopes Market forecast, 2008-2018 “analyzes the market of devices by segments such as, Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. With a Market Value of $0.27 billion and $0.22 billion, Laparoscope and Arthroscope segments have been contributing 25.9% and 21.2% in terms of total Global Rigid Endoscopes Market. All of these segments experienced a positive growth with an increased awareness of patients and physicians towards the usage and reception of new Endoscopy technologies due to the numerous advantages offered by Rigid Endoscopes devices.
The demand for Rigid Endoscopes has increased significantly, largely because of patients’ preference for minimally invasive surgeries. Endoscopic procedures are low-risk procedures and are easily covered by health insurance. A pivotal factor that propels the growth of the endoscopy market is the rapid rise in the number of elderly people who are prone to orthopedic, gastrointestinal, and ophthalmic, diseases as well as cancer. As per the World Health Organization (WHO), between 2000 and 2050, the proportion of the world's population that is aged 60 years will double from about 11% to 22%. This aging population is the main end user of knee-hip implants, bariatric surgeries, gastrointestinal endoscopy, and colonoscopy procedures. With the growing number of elderly people, age-related ailments are also expected to rise sharply, thus propelling the demand and consumption of Rigid Endoscopes devices concomitantly.
The number of people in the world who are obese or overweight has topped 2.1 billion, up from 875 million in 1980. Furthermore, Approximately 7 million people in the United States have some symptoms of Gastroesophageal Reflux Disorder (GERD). Primary or secondary GERD diagnosis increased by an unprecedented 216 percent or from a total of 995,402 individuals diagnosed in 1998 to 3,141,965 in 2005. 4.2 percent of all people hospitalized with GERD in 2005 also had an esophageal disorder. In the United States, 1,150 deaths in 2004 were directly related to a primary diagnosis of GERD. Endoscopic treatments for GERD are newer and are still being studied but are likely to grow in the coming years.
North America accounts highest share of the Global Rigid Endoscopes Devices Market followed by Europe, Asia, and Rest of the World. North America and Europe both are likely to witness a demand for endoscopes as a result of technological advancements as well as improved reimbursement status in both the geographies. Rapidly aging population, increased obesity rates, growing incidence of associated disease are some of the major factors driving the European Rigid Endoscopes market.
The report also provides an extensive competitive landscaping of companies operating in Rigid Endoscopes market. The key players in Rigid Endoscopes segment are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of Rigid Endoscopes products (Segment wise)
- Product Matrix which gives a detailed comparison of Rigid Endoscopes product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the Rigid Endoscopes products (Segment wise and Country wise)
- Comprehensive coverage of Rigid Endoscopes Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), gynecological disorders.
- Country specific Patient pool of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), gynecological disorders.
- Disease progression (Pattern analysis)
Procedure Volume Data
- Different types of Rigid Endoscopes Procedures Performed annually in each country tracked till sub- segment level.
- No of Abdominal, Gastro Intestinal, Interior of joints, Gynecology, Bronchology, Large & Small Intestinal Procedures Performed in each country.
Surgeons/Physicians Perception Matrix
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost Analysis of Rigid Endoscopes Devices in Various Countries.
- Abdominal, Gastro Intestinal, Interior of joints, Gynecology, Bronchology, Large & Small Intestinal procedural investment in major countries.
Competitive Intelligence
- The company share analysis of Rigid Endoscopes devices for the top players of the market in the region.
- The crucial developments and strategies of companies inculcating in their portfolio for Rigid Endoscopes Devices.
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Endoscopes Market The North American endoscope market was valued at $4.9 billion in 2013 and is expected to reach $6.8 billion by 2018, growing at a CAGR of 6.8% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
European Endoscopes Market The European endoscope market was valued at $3.2 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 5.7% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
Asian Endoscopes Market The Asian endoscope market was valued at $2.9 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 7.6% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
